(Q46466735)

22 December 2017

title

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus (English)

1 reference

22 December 2017

1 reference

E Mannucci

1

1 reference

22 December 2017

L Pala

2

1 reference

22 December 2017

S Ciani

3

1 reference

22 December 2017

G Bardini

4

1 reference

22 December 2017

A Pezzatini

5

1 reference

22 December 2017

I Sposato

6

1 reference

22 December 2017

F Cremasco

7

1 reference

22 December 2017

A Ognibene

8

1 reference

22 December 2017

C M Rotella

9

1 reference

22 December 2017

publication date

29 April 2005

1 reference

22 December 2017

published in

Diabetologia

1 reference

22 December 2017

volume

48

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

1168-1172

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-005-1749-8

exact match

0 references

cites work

Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus

1 reference

12 December 2020

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

12 December 2020

Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance

1 reference

12 December 2020

1 reference

12 December 2020

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

1 reference

12 December 2020

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

1 reference

12 December 2020

Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects

1 reference

12 December 2020

Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes

1 reference

12 December 2020

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

12 December 2020

The Inhibitory Effect of Glucagon-Like Peptide-1 (7-36)amide on Antral Motility is Antagonized by Its N-Terminally Truncated Primary Metabolite GLP-1 (9-36)amide

1 reference

12 December 2020

Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.

1 reference

12 December 2020

Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).

1 reference

12 December 2020

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

12 December 2020

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

12 December 2020

The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.

1 reference

12 December 2020

Reference values for plasma dipeptidyl-peptidase IV activity and their association with other laboratory parameters

1 reference

12 December 2020

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

1 reference

12 December 2020

Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose

1 reference

12 December 2020

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

1 reference

12 December 2020

Incretin hormone expression in the gut of diabetic mice and rats

1 reference

12 December 2020

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

1 reference

12 December 2020

Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells.

1 reference

12 December 2020

Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.

1 reference

12 December 2020

10.1007/S00125-005-1749-8

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15864535

1 reference

22 December 2017